These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 20635112

  • 1. Cognitive deficits in experimental autoimmune encephalomyelitis: neuroinflammation and synaptic degeneration.
    Mandolesi G, Grasselli G, Musumeci G, Centonze D.
    Neurol Sci; 2010 Nov; 31(Suppl 2):S255-9. PubMed ID: 20635112
    [Abstract] [Full Text] [Related]

  • 2. Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.
    Ziehn MO, Avedisian AA, Tiwari-Woodruff S, Voskuhl RR.
    Lab Invest; 2010 May; 90(5):774-86. PubMed ID: 20157291
    [Abstract] [Full Text] [Related]

  • 3. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
    Mandolesi G, De Vito F, Musella A, Gentile A, Bullitta S, Fresegna D, Sepman H, Di Sanza C, Haji N, Mori F, Buttari F, Perlas E, Ciotti MT, Hornstein E, Bozzoni I, Presutti C, Centonze D.
    J Neurosci; 2017 Jan 18; 37(3):546-561. PubMed ID: 28100738
    [Abstract] [Full Text] [Related]

  • 4. Neurodegeneration and inflammation in hippocampus in experimental autoimmune encephalomyelitis induced in rats by one--time administration of encephalitogenic T cells.
    Kurkowska-Jastrzębska I, Swiątkiewicz M, Zaremba M, Cudna A, Piechal A, Pyrzanowska J, Widy-Tyszkiewicz E, Członkowska A.
    Neuroscience; 2013 Sep 17; 248():690-8. PubMed ID: 23806721
    [Abstract] [Full Text] [Related]

  • 5. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis.
    Centonze D, Muzio L, Rossi S, Cavasinni F, De Chiara V, Bergami A, Musella A, D'Amelio M, Cavallucci V, Martorana A, Bergamaschi A, Cencioni MT, Diamantini A, Butti E, Comi G, Bernardi G, Cecconi F, Battistini L, Furlan R, Martino G.
    J Neurosci; 2009 Mar 18; 29(11):3442-52. PubMed ID: 19295150
    [Abstract] [Full Text] [Related]

  • 6. Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
    Gentile A, Musella A, Bullitta S, Fresegna D, De Vito F, Fantozzi R, Piras E, Gargano F, Borsellino G, Battistini L, Schubart A, Mandolesi G, Centonze D.
    J Neuroinflammation; 2016 Aug 26; 13(1):207. PubMed ID: 27566665
    [Abstract] [Full Text] [Related]

  • 7. Neurodegeneration in autoimmune CNS inflammation.
    Herz J, Zipp F, Siffrin V.
    Exp Neurol; 2010 Sep 26; 225(1):9-17. PubMed ID: 19961850
    [Abstract] [Full Text] [Related]

  • 8. Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis.
    Musella A, Gentile A, Guadalupi L, Rizzo FR, De Vito F, Fresegna D, Bruno A, Dolcetti E, Vanni V, Vitiello L, Bullitta S, Sanna K, Caioli S, Balletta S, Nencini M, Buttari F, Stampanoni Bassi M, Centonze D, Mandolesi G.
    Cells; 2020 May 22; 9(5):. PubMed ID: 32455907
    [Abstract] [Full Text] [Related]

  • 9. IL-1β dependent cerebellar synaptopathy in a mouse mode of multiple sclerosis.
    Mandolesi G, Gentile A, Musella A, Centonze D.
    Cerebellum; 2015 Feb 22; 14(1):19-22. PubMed ID: 25326653
    [Abstract] [Full Text] [Related]

  • 10. Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis.
    Bourel J, Planche V, Dubourdieu N, Oliveira A, Séré A, Ducourneau EG, Tible M, Maitre M, Lesté-Lasserre T, Nadjar A, Desmedt A, Ciofi P, Oliet SH, Panatier A, Tourdias T.
    Neurobiol Dis; 2021 Dec 22; 160():105533. PubMed ID: 34673149
    [Abstract] [Full Text] [Related]

  • 11. Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis.
    Nisticò R, Mori F, Feligioni M, Nicoletti F, Centonze D.
    Philos Trans R Soc Lond B Biol Sci; 2014 Jan 05; 369(1633):20130162. PubMed ID: 24298163
    [Abstract] [Full Text] [Related]

  • 12. Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.
    Nisticò R, Mango D, Mandolesi G, Piccinin S, Berretta N, Pignatelli M, Feligioni M, Musella A, Gentile A, Mori F, Bernardi G, Nicoletti F, Mercuri NB, Centonze D.
    PLoS One; 2013 Jan 05; 8(1):e54666. PubMed ID: 23355887
    [Abstract] [Full Text] [Related]

  • 13. The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis.
    Centonze D, Muzio L, Rossi S, Furlan R, Bernardi G, Martino G.
    Cell Death Differ; 2010 Jul 05; 17(7):1083-91. PubMed ID: 19927157
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype.
    Hou B, Zhang Y, Liang P, He Y, Peng B, Liu W, Han S, Yin J, He X.
    Cell Death Dis; 2020 May 15; 11(5):377. PubMed ID: 32415059
    [Abstract] [Full Text] [Related]

  • 15. Experimental models of relapsing-remitting multiple sclerosis: current concepts and perspective.
    Skundric DS.
    Curr Neurovasc Res; 2005 Oct 15; 2(4):349-62. PubMed ID: 16181126
    [Abstract] [Full Text] [Related]

  • 16. Differential aspects of immune cell infiltration and neurodegeneration in acute and relapse experimental autoimmune encephalomyelitis.
    Soellner IA, Rabe J, Mauri V, Kaufmann J, Addicks K, Kuerten S.
    Clin Immunol; 2013 Dec 15; 149(3):519-29. PubMed ID: 24239839
    [Abstract] [Full Text] [Related]

  • 17. Persistent activation of microglia and NADPH oxidase [corrected] drive hippocampal dysfunction in experimental multiple sclerosis.
    Di Filippo M, de Iure A, Giampà C, Chiasserini D, Tozzi A, Orvietani PL, Ghiglieri V, Tantucci M, Durante V, Quiroga-Varela A, Mancini A, Costa C, Sarchielli P, Fusco FR, Calabresi P.
    Sci Rep; 2016 Feb 18; 6():20926. PubMed ID: 26887636
    [Abstract] [Full Text] [Related]

  • 18. Reduced Microglial Activity and Enhanced Glutamate Transmission in the Basolateral Amygdala in Early CNS Autoimmunity.
    Acharjee S, Verbeek M, Gomez CD, Bisht K, Lee B, Benoit L, Sharkey KA, Benediktsson A, Tremblay ME, Pittman QJ.
    J Neurosci; 2018 Oct 17; 38(42):9019-9033. PubMed ID: 30185466
    [Abstract] [Full Text] [Related]

  • 19. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
    Larabee CM, Desai S, Agasing A, Georgescu C, Wren JD, Axtell RC, Plafker SM.
    Mol Vis; 2016 Oct 17; 22():1503-1513. PubMed ID: 28050123
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis.
    Guadalupi L, Mandolesi G, Vanni V, Balletta S, Caioli S, Pavlovic A, De Vito F, Fresegna D, Sanna K, Vitiello L, Nencini M, Tartacca A, Mariani F, Rovella V, Schippling S, Ruf I, Collin L, Centonze D, Musella A.
    Neuropharmacology; 2024 Jul 01; 252():109940. PubMed ID: 38570068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.